skip to main content

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > macrocycle > azamacrocycle > 3,3,3-trifluoro-n-[(5r,6r,9s)-5-methoxy-3,6,9-trimethyl-8-(1-methylimidazol-4-yl)sulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > lactam > 3,3,3-trifluoro-n-[(5r,6r,9s)-5-methoxy-3,6,9-trimethyl-8-(1-methylimidazol-4-yl)sulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
organooxygen compound > carboxamide > lactam > 3,3,3-trifluoro-n-[(5r,6r,9s)-5-methoxy-3,6,9-trimethyl-8-(1-methylimidazol-4-yl)sulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > lactam > 3,3,3-trifluoro-n-[(5r,6r,9s)-5-methoxy-3,6,9-trimethyl-8-(1-methylimidazol-4-yl)sulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > lactam > 3,3,3-trifluoro-n-[(5r,6r,9s)-5-methoxy-3,6,9-trimethyl-8-(1-methylimidazol-4-yl)sulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
organic heterocyclic compound > organonitrogen heterocyclic compound > lactam > 3,3,3-trifluoro-n-[(5r,6r,9s)-5-methoxy-3,6,9-trimethyl-8-(1-methylimidazol-4-yl)sulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

Preferred term

3,3,3-trifluoro-n-[(5r,6r,9s)-5-methoxy-3,6,9-trimethyl-8-(1-methylimidazol-4-yl)sulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C24H32F3N5O6S

inchi

  • InChI=1S/C24H32F3N5O6S/c1-15-10-32(39(35,36)22-12-30(3)14-28-22)16(2)13-38-19-8-17(29-21(33)9-24(25,26)27)6-7-18(19)23(34)31(4)11-20(15)37-5/h6-8,12,14-16,20H,9-11,13H2,1-5H3,(H,29,33)/t15-,16+,20+/m1/s1

inchikey

  • ZYJJQNOXPHIYRR-GUXCAODWSA-N

mass

  • 575.603

monoisotopicmass

  • 575.20254

smiles

  • C[C@@H]1CN([C@H](COC2=C(C=CC(=C2)NC(=O)CC(F)(F)F)C(=O)N(C[C@@H]1OC)C)C)S(=O)(=O)C3=CN(C=N3)C

subset

  • 2_STAR

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:97952

Download this concept: